| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.33 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.34 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |